Silverarc Capital Management, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$6.1 - $7.15 $2.82 Million - $3.31 Million	-462,659 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.93 - $7.6 $24,864 - $31,866	4,193 Added 0.91%	462,659 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$6.04 - $8.03 $421,797 - $560,767	69,834 Added 17.97%	458,466 $1.78 Million
Q3 2021 Nov 15, 2021	BUY	$8.02 - $11.0 $1.05 Million - $1.44 Million	130,674 Added 50.66%	388,632 $2.05 Million
Q2 2021 Aug 16, 2021	BUY	$7.59 - $10.48 $60,401 - $83,399	7,958 Added 3.18%	257,958 $1.53 Million
Q1 2021 May 18, 2021	BUY	$6.86 - $9.24 $1.72 Million - $2.31 Million	250,000 New	250,000 $1.78 Million

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $7.9M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.